Applied DNA Sciences Statistics Share Statistics Applied DNA Sciences has 519K
shares outstanding. The number of shares has increased by 0.87%
in one year.
Shares Outstanding 519K Shares Change (YoY) 0.87% Shares Change (QoQ) 1.03% Owned by Institutions (%) 0.08% Shares Floating 513.98K Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 49.24K, so 9.49% of the outstanding
shares have been sold short.
Short Interest 49.24K Short % of Shares Out 9.49% Short % of Float 9.49% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -276.42 and the forward
PE ratio is -0.05.
Applied DNA Sciences's PEG ratio is
3.14.
PE Ratio -276.42 Forward PE -0.05 PS Ratio 563.28 Forward PS n/a PB Ratio 211.41 P/FCF Ratio -136.89 PEG Ratio 3.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Applied DNA Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.36,
with a Debt / Equity ratio of 0.08.
Current Ratio 3.36 Quick Ratio 3.17 Debt / Equity 0.08 Debt / EBITDA -0.06 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $74.6K Profits Per Employee $-152.01K Employee Count 46 Asset Turnover 0.27 Inventory Turnover 5.51
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -0.04, so Applied DNA Sciences's
price volatility has been lower than the market average.
Beta -0.04 52-Week Price Change n/a 50-Day Moving Average 4.94 200-Day Moving Average 74.06 Relative Strength Index (RSI) 36.17 Average Volume (20 Days) n/a
Income Statement In the last 12 months, Applied DNA Sciences had revenue of 3.43M
and earned -6.99M
in profits. Earnings per share was -1.82.
Revenue 3.43M Gross Profit 1.02M Operating Income -14.02M Net Income -6.99M EBITDA -13.33M EBIT -14.02M Earnings Per Share (EPS) -1.82
Full Income Statement Balance Sheet The company has 6.43M in cash and 739.16K in
debt, giving a net cash position of 5.69M.
Cash & Cash Equivalents 6.43M Total Debt 739.16K Net Cash 5.69M Retained Earnings -309.67M Total Assets 13.04M Working Capital 6.54M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -13.71M
and capital expenditures -407.9K, giving a free cash flow of -14.12M.
Operating Cash Flow -13.71M Capital Expenditures -407.9K Free Cash Flow -14.12M FCF Per Share -3.56
Full Cash Flow Statement Margins Gross margin is 29.63%, with operating and profit margins of -408.72% and -203.78%.
Gross Margin 29.63% Operating Margin -408.72% Pretax Margin -206.57% Profit Margin -203.78% EBITDA Margin -388.42% EBIT Margin -408.72% FCF Margin -411.47%
Dividends & Yields APDN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for APDN.
Price Target $1125 Price Target Difference n/a Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 2, 2025. It was a
backward
split with a ratio of 1:15.
Last Split Date Jun 2, 2025 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -40 Piotroski F-Score 4
